This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

2013 US Clinical Chemistry And Immunodiagnostics Markets

by Assay

U.S.A., Commercial/Private Laboratories,

Tumor Markers and Special Chemistry Reagent

Market Forecast by Assay

U.S.A., Physician Offices/Group Practices,

Tumor Markers and Special Chemistry Reagent

Market Forecast by Assay

U.S.A., All Market Segments,

Immunoprotein Reagent Market Forecast

U.S.A., Hospital Laboratories,Immunoprotein

Reagent Market Forecast Immunoprotein

U.S.A., Commercial/Private Laboratories,

Immunoprotein Reagent Market Forecast

U.S.A., Physician Offices/Group Practices,

Immunoprotein Reagent Market Forecast

by Assay

U.S.A., Major Suppliers of Clinical Chemistry

Reagents, Estimated Sales and Market Shares

U.S.A., Major Suppliers of Clinical Chemistry

Analyzers, Estimated Instrument Sales

and Market Shares

U.S.A., Major Suppliers of Clinical Chemistry

Diagnostics Products, Estimated Sales

and Market Shares

U.S.A., Major Suppliers of Immunoassay

Reagents, Estimated Sales and Market Shares

U.S.A., Major Suppliers of Immunoassay

Analyzers, Estimated Instrument Sales

and Market Shares

U.S.A., Major Suppliers of Immunoassay

Diagnostics Products, Estimated Sales

And Market Shares

To order this report:

In_Vitro_Diagnostic Industry : 2013 US Clinical Chemistry and Immunodiagnostics Markets

Contact Nicolas: nicolasbombourg@reportlinker.comUS: (805)-652-2626Intl: +1 805-652-2626

SOURCE Reportlinker

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
8 of 8

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,712.66 +34.43 0.19%
S&P 500 2,061.02 +4.87 0.24%
NASDAQ 4,891.2190 +27.8570 0.57%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs